Compare Royal Caribbean Cruises Ltd (RCL) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Royal Caribbean Cruises Ltd vs Teladoc Health Inc — how do they compare? Royal Caribbean Cruises Ltd trades at $282 (market cap $75.26B), while Teladoc Health Inc trades at $5.79 (market cap $1.01B). The key difference: Royal Caribbean Cruises Ltd is far larger — about 74.5× Teladoc Health Inc's market cap, and Royal Caribbean Cruises Ltd pays a 2.13% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Royal Caribbean Cruises Ltd for 85 Days and Teladoc Health Inc for 39 Days on average.
| RCL | TDOC | |
|---|---|---|
Market Cap | $75.26B | $1.01B |
Volume | 1,958,628 | 4,668,477 |
Sector | Consumer Cyclical | Health |
52-Week High | $348.03 | $9.72 |
52-Week Low | $230.30 | $4.47 |
Typical Hold Time | 85 Days | 39 Days |
Enterprise Value | $97.91B | $1.27B |
Dividend Yield | 2.13% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Royal Caribbean (RCL) trades at $282.26, showing minimal daily movement (-0.04%) amid strong fundamental performance. The stock maintains a bullish technical outlook with support at $279 and resistance at $284. Recent earnings beats in Q1 and Q2 2026, coupled with robust revenue growth from $8.8B in 2022 to $17.9B in 2025, highlight operational strength. The company's expansion into resort markets through the $3B Sandals acquisition adds growth diversification while analyst consensus remains positive with a $346.67 price target.
RCL presents a compelling growth story with expanding profit margins and strategic diversification, though elevated debt levels and fuel cost sensitivity pose moderate risks. The stock's current valuation at 17.38x P/E appears reasonable given 45.33% ROE and consistent earnings outperformance. Near-term catalysts include Q3 2026 earnings and continued execution on the Sandals integration, while macroeconomic pressures on travel demand represent the primary headwind.
Teladoc Health (TDOC) trades at $5.77, up 3.78% today but remains near multi-year lows amid ongoing profitability challenges. The stock shows bearish technical signals with mixed earnings performance, having beaten estimates in two of the last three quarters but posting consistent net losses. Recent management changes include the appointment of a new CFO and legal officer as the company focuses on stabilizing its integrated care business while grappling with BetterHelp segment weakness.
While TDOC trades at discounted valuation multiples (P/S 0.4x, P/B 0.77x) and analysts maintain a $8.83 price target, the path to profitability remains uncertain given seven consecutive quarters of negative earnings. The primary investment thesis hinges on the company's ability to monetize its chronic care platform and achieve sustainable free cash flow generation, though investor sentiment remains cautious amid ongoing losses and competitive pressures in virtual healthcare.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Royal Caribbean Cruises Ltd
Royal Caribbean is the world's second-largest cruise company, operating 64 ships across five global and partner brands in the cruise vacation industry, with 10 more ships on order. Brands the company operates include Royal Caribbean International, Celebrity Cruises, and Silversea. The company also has a 50% investment in a joint venture that operates TUI Cruises and Hapag-Lloyd Cruises, allowing it to compete on the basis of innovation, quality of ships and service, variety of itineraries, choice of destinations, and price. The company completed the divestiture of its Azamara brand in the first quarter of 2021.
Read more on RCL →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
